Related Experiment Video

Updated: Jun 13, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
07:43

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Published on: October 18, 2018

[Helicobacter pylori infection: from gastric to systemic disease]

Giovanni Gasbarrini1, Simona Racco, Francesco Franceschi

  • 1Istituto di Medicina Interna, Policlinico Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma.

Recenti Progressi in Medicina
|April 16, 2010
PubMed

Insights

Helicobacter pylori (H. pylori) infection causes most gastroduodenal diseases and some extragastric disorders by chronically stimulating the immune system. Molecular mimicry mechanisms link H. pylori to conditions like sideropenic anemia and idiopathic thrombocytopenic purpura.

Area of Science:

  • Gastroenterology
  • Immunology
  • Infectious Diseases

Background:

  • Helicobacter pylori (H. pylori) is a major pathogen linked to gastroduodenal diseases.
  • Chronic immune stimulation and molecular mimicry are key pathogenic mechanisms.
  • H. pylori's role extends beyond the stomach to extragastric conditions.

Purpose of the Study:

  • To elucidate the pathogenic role of H. pylori in gastroduodenal and extragastric disorders.
  • To highlight the contribution of chronic immune stimulation and molecular mimicry.
  • To identify H. pylori-associated diseases currently under investigation.

Main Methods:

  • Review of existing literature on H. pylori pathogenesis.
  • Analysis of immune system responses to H. pylori infection.
  • Investigation of molecular mimicry pathways.

Main Results:

  • H. pylori infection is responsible for the majority of gastroduodenal diseases.
  • H. pylori is implicated in extragastric disorders such as sideropenic anemia and idiopathic thrombocytopenic purpura.
  • Ongoing research is exploring additional H. pylori-associated conditions.

Conclusions:

  • H. pylori infection is a significant cause of diverse gastrointestinal and systemic diseases.
  • Immune dysregulation and molecular mimicry are central to H. pylori's pathogenicity.
  • Further research is warranted to fully understand the spectrum of H. pylori-related disorders.

More Related Videos

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability09:05

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...